Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy.

Demir M, Oba E, Can E, Kara O, Cinar S.

Ophthalmol Eye Dis. 2013 Jul 15;5:11-5. doi: 10.4137/OED.S12352. Print 2013.

2.

Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy.

Li CR, Sun SG, Hong W.

Int J Ophthalmol. 2010;3(3):261-3. doi: 10.3980/j.issn.2222-3959.2010.03.19. Epub 2010 Sep 18.

3.

The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.

Ahn J, Woo SJ, Chung H, Park KH.

Ophthalmology. 2011 Nov;118(11):2218-26. doi: 10.1016/j.ophtha.2011.03.036. Epub 2011 Jul 2.

PMID:
21724263
4.

Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.

Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R.

Ophthalmology. 2009 Oct;116(10):1943-8. doi: 10.1016/j.ophtha.2009.07.001. Epub 2009 Aug 21.

PMID:
19699531
5.

Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.

Park DH, Shin JP, Kim SY.

Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):641-50. doi: 10.1007/s00417-009-1247-7. Epub 2009 Dec 12.

PMID:
20012643
6.

Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.

Oshima Y, Shima C, Wakabayashi T, Kusaka S, Shiraga F, Ohji M, Tano Y.

Ophthalmology. 2009 May;116(5):927-38. doi: 10.1016/j.ophtha.2008.11.005. Epub 2009 Mar 9.

PMID:
19269033
7.

Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Smith JM, Steel DH.

Cochrane Database Syst Rev. 2015 Aug 7;(8):CD008214. doi: 10.1002/14651858.CD008214.pub3. Review.

PMID:
26250103
8.

Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.

Gupta A, Bansal R, Gupta V, Dogra MR.

Int Ophthalmol. 2012 Apr;32(2):135-44. doi: 10.1007/s10792-012-9541-5. Epub 2012 Mar 27.

PMID:
22450558
9.

Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.

di Lauro R, De Ruggiero P, di Lauro R, di Lauro MT, Romano MR.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. doi: 10.1007/s00417-010-1303-3. Epub 2010 Feb 5.

PMID:
20135139
10.

Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.

Sato T, Morita S, Bando H, Sato S, Ikeda T, Emi K.

Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):51-5. doi: 10.4103/0974-9233.106387.

11.

The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.

Berk Ergun S, Toklu Y, Cakmak HB, Raza S, Simsek S.

Semin Ophthalmol. 2015 May;30(3):177-80. doi: 10.3109/08820538.2013.835847. Epub 2014 Jan 10.

PMID:
24409948
12.

Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.

Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM.

Eur J Ophthalmol. 2009 Sep-Oct;19(5):848-52.

PMID:
19787608
13.
14.

Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).

Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G.

Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):837-42. doi: 10.1007/s00417-008-0774-y. Epub 2008 Feb 20.

PMID:
18286296
15.
16.

Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study.

Raizada S, Al Kandari J, Al Diab F, Al Sabah K, Kumar N, Mathew S.

Indian J Ophthalmol. 2015 Jun;63(6):504-10. doi: 10.4103/0301-4738.162602.

17.

RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.

Manabe A, Shimada H, Hattori T, Nakashizuka H, Yuzawa M.

Retina. 2015 Sep;35(9):1800-7. doi: 10.1097/IAE.0000000000000577.

PMID:
25932549
18.

The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.

Göncü T, Özdek S, Ünlü M.

Eur J Ophthalmol. 2014 Jan-Feb;24(1):88-93. doi: 10.5301/ejo.5000327. Epub 2013 Jun 17.

PMID:
23787453
19.

Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.

Parikh RN, Traband A, Kolomeyer AM, VanderBeek BL, Kim BJ, Maguire AM, Brucker AJ.

Am J Ophthalmol. 2017 Apr;176:194-202. doi: 10.1016/j.ajo.2017.01.010. Epub 2017 Jan 24.

PMID:
28130042
20.

[Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].

Naser H, Koss MJ, Singh P, Koch F.

Klin Monbl Augenheilkd. 2011 Oct;228(10):910-4. doi: 10.1055/s-0029-1245965. Epub 2011 Oct 13. German.

PMID:
21997827

Supplemental Content

Support Center